5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.29▼ | 3.29▼ | 3.29▼ | 3.28▼ | 3.21▼ |
MA10 | 3.32▼ | 3.35▼ | 3.33▼ | 3.28▼ | 3.23▼ |
MA20 | 3.38▼ | 3.38▼ | 3.38▼ | 3.23▼ | 3.28▼ |
MA50 | 3.40▼ | 3.34▼ | 3.29▼ | 3.25▼ | 4.00▼ |
MA100 | 3.31▼ | 3.26▼ | 3.26▼ | 3.26▼ | 4.23▼ |
MA200 | 3.27▼ | 3.37▼ | 3.31▼ | 3.95▼ | 7.87▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.021▼ | -0.027▼ | -0.027▼ | 0.000▲ | 0.051▲ |
RSI | 39.953▼ | 39.903▼ | 42.358▼ | 45.606▼ | 44.122▼ |
STOCH | 16.548▼ | 15.610▼ | 13.314▼ | 41.975 | 32.488 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -75.000▼ | -69.849 |
CCI | -121.558▼ | -115.508▼ | -118.935▼ | -50.320 | -37.574 |
MA | $LPCN Price Crossed Below MA(26) | Set Alert |
Tuesday, July 01, 2025 09:08 AM
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave and Chime and a ...
|
Friday, June 27, 2025 11:56 AM
Lipocine has initiated subject dosing in its two-arm, blinded, randomised Phase III trial of LPCN 1154 (oral brexanolone) for postpartum depression (PPD). This follows feedback from the Food and ...
|
Thursday, June 26, 2025 06:00 AM
Lipocine is exploring partnering opportunities for LPCN 1107, our candidate for prevention of preterm birth, LPCN 1154, for rapid relief of postpartum depression, LPCN 2401 for obesity management ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/08/25 | 3.2924 | 3.2924 | 3.12 | 3.15 | 21,720 |
31/07/25 | 3.32 | 3.4474 | 3.23 | 3.23 | 8,711 |
30/07/25 | 3.27 | 3.4315 | 3.27 | 3.33 | 6,921 |
29/07/25 | 3.36 | 3.3709 | 3.24 | 3.27 | 16,065 |
28/07/25 | 3.46 | 3.5288 | 3.27 | 3.3977 | 18,884 |
25/07/25 | 3.36 | 3.60 | 3.30 | 3.44 | 33,440 |
24/07/25 | 3.30 | 3.58 | 3.2911 | 3.32 | 55,905 |
23/07/25 | 3.29 | 3.48 | 3.26 | 3.27 | 129,414 |
22/07/25 | 3.15 | 3.2808 | 3.1269 | 3.26 | 51,237 |
21/07/25 | 3.14 | 3.26 | 3.10 | 3.17 | 37,338 |
|
|
||||
|
|
||||
|
|